← All organizations
Medicine Invention Design, Inc
For profit
Also known as: Dr. Han Xu | Dr. Han Xu, President/CEO / PD / PI / Monitor / IRB Chair | Han Xu, M.D., Ph.D., Sponsor-Investigator-Monitor, IRB Chair | IORG0007849 | IRB00009424 | Medicine Invention Design, Inc | Medicine Invention Design, Inc. - IORG0007849 | Medicine Invention Design, Inc. - IORG0007849 - NPI-1023387701 | MIDINC Clinical Research Multiple Group Unit
Highest phase reached
Phase 3
First clinical trial
Aug 1, 2016Last known activity
Sep 12, 2025
Timeline
2000s
- Jun 1, 2006
Medicine Invention Design, Inc— Founded
Drugs by trial phase (12 distinct, 10 trials)
Phase 3 (10 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (40)
- NCT07182838Lead sponsorEarly Phase 1Sep 12, 2025
- NCT07182838Sponsor investigatorEarly Phase 1Sep 12, 2025
- NCT07145333OfficialPhase 2/Phase 3Aug 12, 2025
- NCT07145333Lead sponsorPhase 2/Phase 3Aug 12, 2025
- NCT07145333Sponsor investigatorPhase 2/Phase 3Aug 12, 2025
- NCT07033585Sponsor investigatorPhase 2/Phase 3Jun 15, 2025
- NCT07033585OfficialPhase 2/Phase 3Jun 15, 2025
- NCT07033585Lead sponsorPhase 2/Phase 3Jun 15, 2025
- NCT06959563Sponsor investigatorEarly Phase 1Apr 28, 2025
- NCT06959563Lead sponsorEarly Phase 1Apr 28, 2025
- NCT06062810Lead sponsorPhase 2/Phase 3Mar 28, 2024
- NCT06062810Overall official - principal investigatorPhase 2/Phase 3Mar 28, 2024
- NCT06062810Sponsor investigatorPhase 2/Phase 3Mar 28, 2024
- NCT06062810Study chairPhase 2/Phase 3Mar 28, 2024
- NCT06062810Study directorPhase 2/Phase 3Mar 28, 2024
Details
- Founded
- Gaithersburg, MD, US Jun 1, 2006
- Last known activity
- Sep 12, 2025
Notes
CRO